AbbVie Inc. is 103.4x more valuable than Oruka Therapeutics, Inc. by market capitalization ($399.47 B vs $3.86 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ORKA | ABBV |
|---|---|---|
| Market cap | $3.86 B | $399.47 B |
| US-listed rank | #1601 | #28 |
| Revenue (latest FY) | $0.00 | $61.16B |
| Net income (latest FY) | -$105.43M | $4.23B |
| Net margin | - | 6.9% |
| P/E (trailing FY) | - | 94.5 |
| SEC filings | 1,475 | 1,008 |
AbbVie Inc. is 103.4x more valuable than Oruka Therapeutics, Inc. by market capitalization ($399.47 B vs $3.86 B).
In their latest fiscal years, Oruka Therapeutics, Inc. reported $0.00 in revenue while AbbVie Inc. reported $61.16B.
Full pages: Oruka Therapeutics, Inc. and AbbVie Inc., or browse the full rankings.